JP2001527412A5 - - Google Patents

Download PDF

Info

Publication number
JP2001527412A5
JP2001527412A5 JP1998549512A JP54951298A JP2001527412A5 JP 2001527412 A5 JP2001527412 A5 JP 2001527412A5 JP 1998549512 A JP1998549512 A JP 1998549512A JP 54951298 A JP54951298 A JP 54951298A JP 2001527412 A5 JP2001527412 A5 JP 2001527412A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP1998549512A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001527412A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1998/009796 external-priority patent/WO1998051794A1/en
Publication of JP2001527412A publication Critical patent/JP2001527412A/ja
Publication of JP2001527412A5 publication Critical patent/JP2001527412A5/ja
Withdrawn legal-status Critical Current

Links

JP54951298A 1997-05-14 1998-05-14 抗菌ペプチド Withdrawn JP2001527412A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4641597P 1997-05-14 1997-05-14
US60/046,415 1997-05-14
PCT/US1998/009796 WO1998051794A1 (en) 1997-05-14 1998-05-14 Antimicrobial peptide

Publications (2)

Publication Number Publication Date
JP2001527412A JP2001527412A (ja) 2001-12-25
JP2001527412A5 true JP2001527412A5 (enExample) 2005-12-08

Family

ID=21943326

Family Applications (1)

Application Number Title Priority Date Filing Date
JP54951298A Withdrawn JP2001527412A (ja) 1997-05-14 1998-05-14 抗菌ペプチド

Country Status (8)

Country Link
US (3) US6143498A (enExample)
EP (1) EP0980431A1 (enExample)
JP (1) JP2001527412A (enExample)
KR (1) KR20010012554A (enExample)
CN (1) CN1260834A (enExample)
AU (1) AU737710B2 (enExample)
CA (1) CA2290781A1 (enExample)
WO (1) WO1998051794A1 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6984622B2 (en) * 1998-03-25 2006-01-10 The Regents Of The University Of California Use of lipopolysaccharides to manage corneal infections and wounds
AU7725500A (en) * 1999-09-30 2001-04-30 National Jewish Medical And Research Center Method for inhibition of pathogenic microorganisms
ES2199098T3 (es) * 2000-06-08 2006-10-01 Ipf Pharmaceuticals Gmbh Procedimiento para la obtencion y uso de peptidos de efecto antibiotico para el tratamiento de enfermedades infecciosas.
US6846804B2 (en) * 2000-06-29 2005-01-25 University Of Maryland, College Park Office Of Technology Commercialization Construction of a structural variant of sublancin to facilitate its isolation and use in bioremediation of environmental contamination by gram-positive spore formers such as bacillus anthrasis
DE10129983A1 (de) * 2001-06-13 2003-01-30 Univ Eberhard Karls Antimikrobiell wirkendes Peptid
US8329865B2 (en) * 2001-06-13 2012-12-11 Eberhard-Karls-Univresitaet Tuebingen Universitaetsklinikum Antimicrobially active peptides
US7507787B2 (en) * 2001-12-03 2009-03-24 The University Of British Columbia Effectors of innate immunity
US7511015B2 (en) * 2002-02-19 2009-03-31 The United States Of America As Represented By The Department Of Health And Human Services Modified defensins and their use
AU2003231471A1 (en) 2002-04-25 2003-11-10 Toagosei Co., Ltd. Antimicrobial polypeptide and utizliation thereof
US7033769B2 (en) * 2002-05-23 2006-04-25 The United States Of America As Represented By The Secretary Of The Army Method for discovering one or more peptides adapted for specific binding to a microorganism of interest
JP4524671B2 (ja) 2003-10-29 2010-08-18 東亞合成株式会社 抗菌ペプチド及びその利用
JP4507080B2 (ja) 2004-07-30 2010-07-21 東亞合成株式会社 抗菌ペプチド及びその利用
JP4730584B2 (ja) 2004-12-06 2011-07-20 東亞合成株式会社 抗菌ペプチド及びその利用
WO2006083927A2 (en) * 2005-01-31 2006-08-10 Coram Bioscience, Inc. Antimicrobial agent
JP5041231B2 (ja) 2005-02-15 2012-10-03 東亞合成株式会社 抗菌ペプチド及びその利用
US20070231833A1 (en) * 2005-05-23 2007-10-04 Arcidiacono Steven M Labeled antimicrobial peptides and method of using the same to detect microorganisms of interest
US8691945B2 (en) * 2006-04-27 2014-04-08 Singapore Health Services Pte Ltd. Antimicrobial peptides
US20100150985A1 (en) * 2008-04-24 2010-06-17 George Just Dental Implant, Endodontic Instrument, and Dental Filling Material Coated with a Peptide-Based Antimicrobial and Methods of Using and Making the Same
FR2944019B1 (fr) * 2009-04-03 2011-04-22 Biomerieux Sa Procede de dosage de la prodefensine-a6 pour le diagnostic in vitro du cancer colorectal.
WO2011137368A2 (en) 2010-04-30 2011-11-03 Life Technologies Corporation Systems and methods for analyzing nucleic acid sequences
US9268903B2 (en) 2010-07-06 2016-02-23 Life Technologies Corporation Systems and methods for sequence data alignment quality assessment
KR101303299B1 (ko) * 2010-10-08 2013-09-03 재단법인 지능형 바이오 시스템 설계 및 합성 연구단 항균 펩타이드의 피부 세포 재생 촉진제로서의 신규한 용도
US10967031B2 (en) 2010-12-28 2021-04-06 Kamedis Ltd. Synergistic herbal compositions with prebiotic properties for treatment of skin infections, allergies and inflammation
KR101947126B1 (ko) 2010-12-28 2019-02-13 카메디스 리미티드 감염의 치료 및 예방을 위한 식물 추출물
EA035645B1 (ru) 2013-03-15 2020-07-21 Дженентек, Инк. ПОЛИПЕПТИДЫ IL-22, ХИМЕРНЫЕ БЕЛКИ IL-22 Fc И ИХ ПРИМЕНЕНИЕ
US11612225B2 (en) * 2018-05-03 2023-03-28 Nicholas Schwartz Securing beach net
WO2021163630A1 (en) 2020-02-13 2021-08-19 10X Genomics, Inc. Systems and methods for joint interactive visualization of gene expression and dna chromatin accessibility
US12472231B2 (en) 2020-03-18 2025-11-18 The University Of Hong Kong Compositions of anti-viral peptides and methods of use thereof
EP4457237A4 (en) * 2021-12-27 2025-11-12 Versitech Ltd ANTIVIRAL PEPTIDES AND THEIR METHODS OF USE
CN116496916A (zh) * 2022-12-27 2023-07-28 安徽斯拜科生物科技有限公司 一种高产hbd-2的毕赤酵母工程菌株及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5432270A (en) * 1990-10-25 1995-07-11 Zasloff; Michael A. DNA encoding tracheal antimicrobial peptides
AU670108B2 (en) 1992-09-11 1996-07-04 Becton Dickinson & Company Improved antibodies to plasmodium falciparum
US5470955A (en) 1993-02-02 1995-11-28 Dartmouth College Antibodies which specifically bind mcl-1 polypeptide
DE4427531A1 (de) * 1994-08-04 1996-02-08 Forssmann Wolf Georg Humanes zirkulierendes beta-Defensin hBD-1
DE19629119A1 (de) * 1995-12-16 1997-06-19 Beiersdorf Ag Gegen Bakterien, Mycota und Viren wirksame kosmetische Zubereitungen enthaltend Vertebratenproteine
JP4001383B2 (ja) * 1995-12-16 2007-10-31 プラントン・ゲゼルシヤフト・ミット・ベシュレンクテル・ハフツング 細菌、菌類、およびウイルスに対して有効で、かつ脊椎動物性蛋白質を含む化粧用製剤

Similar Documents

Publication Publication Date Title
JP2000509912A5 (enExample)
JP2000507042A5 (enExample)
JP2000509637A5 (enExample)
JP2000509635A5 (enExample)
JP2000509942A5 (enExample)
JP2000510751A5 (enExample)
JP2000509587A5 (enExample)
JP2000507369A5 (enExample)
JP2000507433A5 (enExample)
JP2001501070A5 (enExample)
JP2000508866A5 (enExample)
JP2000510793A5 (enExample)
JP2000508022A5 (enExample)
JP2000508841A5 (enExample)
JP2000508680A5 (enExample)
JP2000509804A5 (enExample)
JP2000509853A5 (enExample)
JP2000509755A5 (enExample)
JP2000510247A5 (enExample)
JP2000510969A5 (enExample)
JP2000508836A5 (enExample)
JP2000508102A5 (enExample)
JP2000509818A5 (enExample)
JP2000509520A5 (enExample)
JP2000507434A5 (enExample)